[1] |
胡皓夫,曹利静. 小儿肺炎的治疗[J]. 实用儿科临床杂志, 2011, 26(4):239-240.
|
[2] |
中华医学会儿科学呼吸学组,中华儿科杂志编辑委员会, 儿童社区获得性肺炎管理指南(试行) [J].中华儿科杂志, 2007,45(2):83-90.
|
[3] |
Xu L, Liu J, Liu C, et al. Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008-2013[J]. BMC Infect Dis, 2018,18(1):634.
|
[4] |
赵爱玲,王雪琴,王江涛. 人巨细胞病毒感染与小婴儿肺炎的临床分析[J]. 医药论坛杂志, 2019,40(5):37-38.
|
[5] |
方峰. 儿童巨细胞病毒性疾病诊断和防治的建议[J]. 中华儿科杂志,2012,11(4):290-292.
|
[6] |
张鑫婷,于泽堃,韩宗来, 等. 新生儿巨细胞病毒肺炎诊断及治疗[J]. 中国妇幼保健, 2018,33(15):3597-3600.
|
[7] |
黄莉,张新星,顾文婧, 等. 肺炎支原体与EB病毒混合感染后肺炎的临床及实验室特征[J]. 临床儿科杂志, 2015,33(8):690-693.
|
[8] |
DeAntonio R, Yarzabal JP, Cruz JP, et al. Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review[J]. Hum Vaccin Immunother, 2016,12(9):2422-2440.
|
[9] |
赵云,王紫荆,彭程. 多重核酸检测在儿童下呼吸道感染病原学诊断中的应用分析[J]. 中国优生与遗传杂志, 2019,11:1405-1408.
|
[10] |
李昌崇,尚云晓,沈叙庄, 等. 儿童社区获得性肺炎管理指南(2013修订)(下)[J]. 中华儿科杂志, 2013,51(11):856-862.
|
[11] |
郑荣,蒋娇伏,姚冬梅. 小儿社区获得性肺炎病原及其耐药性分析[J]. 中国医学工程, 2007,7(10):806-808.
|
[12] |
Donald MT, Seidenberg P, Daniel EP, et al. Limited utility of polymerase chain reaction in induced sputum specimens for determining the causes of childhood pneumonia in resource-poor settings: findings from the pneumonia etiology research for child health (PERCH) study.[J].Clin infect dis, 2017, 64(Suppl 3):S289-S300.
|
[13] |
Rudan I, O'Brien K L, Nair H, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries[J]. J Glob Health, 2013,3(1):10401.
|
[14] |
李娜,杨蕊嘉,叶倩, 等. 婴幼儿下呼吸道肺炎克雷伯菌感染及其耐药性研究[J]. 现代预防医学, 2012,39(23):6126-6129.
|
[15] |
刘娟,尚彪,白静, 等. 749例社区获得性肺炎儿童的病原体分布特点[J]. 西部医学, 2019,31(5):731-736.
|